Cyabra, Inc. Total Cost of Revenue decreased by 2.0% to $192.00K in Q1 2026 compared to the prior quarter. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q1 '25 | Q1 '26 | |
|---|---|---|
| Value | $196.00K | $192.00K |
| QoQ Change | — | -2.0% |
| YoY Change | — | -2.0% |